Sheila Vora

Associate Director Clinical Research at ADC Therapeutics - New Providence, NJ, US

Sheila Vora's Colleagues at ADC Therapeutics
David Ungar

Head of US Oncology Clinical Development

Contact David Ungar

Einav Leberknight

Sr. Director, Clinical Operations

Contact Einav Leberknight

David Ellis

Vice President, Head of Regulatory Affairs

Contact David Ellis

Nick Finnie

Head of Intellectual Property

Contact Nick Finnie

View All Sheila Vora's Colleagues
Sheila Vora's Contact Details
HQ
908-731-5556
Location
Monmouth Junction, New Jersey
Company
ADC Therapeutics
Sheila Vora's Company Details
ADC Therapeutics logo, ADC Therapeutics contact details

ADC Therapeutics

New Providence, NJ, US • 250 - 499 Employees
BioTech/Drugs

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.  These proprietary PBD-based ADCs are expected to provide a novel way to treat hematological cancers and solid tumors, address significant unmet medical needs, and improve the lives of patients with cancer. Our mission is to confront cancer with the full potential of our science to bring unique, targeted therapies and hope to patients and their families.

N/A
Details about ADC Therapeutics
Frequently Asked Questions about Sheila Vora
Sheila Vora currently works for ADC Therapeutics.
Sheila Vora's role at ADC Therapeutics is Associate Director Clinical Research.
Sheila Vora's email address is ***@adctherapeutics.com. To view Sheila Vora's full email address, please signup to ConnectPlex.
Sheila Vora works in the BioTech/Drugs industry.
Sheila Vora's colleagues at ADC Therapeutics are David Ungar, Einav Leberknight, David Ellis, Mike Cutcliff, Nick Finnie, Cristina Aller Garcia, Nicola Tsang and others.
Sheila Vora's phone number is 908-731-5556
See more information about Sheila Vora